Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue.

Konnikova L, Boschetti G, Rahman A, Mitsialis V, Lord J, Richmond C, Tomov VT, Gordon W, Jelinsky S, Canavan J, Liss A, Wall S, Field M, Zhou F, Goldsmith JD, Bewtra M, Breault DT, Merad M, Snapper SB.

Mucosal Immunol. 2018 Aug 15. doi: 10.1038/s41385-018-0047-y. [Epub ahead of print]

PMID:
30111863
2.

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.

Lewis JD, Scott FI, Brensinger CM, Roy JA, Osterman MT, Mamtani R, Bewtra M, Chen L, Yun H, Xie F, Curtis JR.

Am J Gastroenterol. 2018 Mar;113(3):405-417. doi: 10.1038/ajg.2017.479. Epub 2018 Jan 16.

3.

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, Malietzis G, Lee GH, Eruslanov E, Albelda SM, Wang X, Mehta JL, Bewtra M, Rustgi A, Hockstein N, Witt R, Masters G, Nam B, Smirnov D, Sepulveda MA, Gabrilovich DI.

Sci Immunol. 2016 Aug;1(2). pii: aaf8943. doi: 10.1126/sciimmunol.aaf8943. Epub 2016 Aug 5.

4.

State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey.

Cohen BL, Ha C, Ananthakrishnan AN, Rieder F, Bewtra M.

Inflamm Bowel Dis. 2016 Jul;22(7):1609-15. doi: 10.1097/MIB.0000000000000766.

5.

Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.

Rieder F, Cohen BL, Dotson JL, Bewtra M, Ananthakrishnan AN, Falaiye TO, Ha CY.

Inflamm Bowel Dis. 2016 Jun;22(6):1531-2. doi: 10.1097/MIB.0000000000000814. No abstract available.

6.

Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.

Thompson KD, Connor SJ, Walls DM, Gollins J, Stewart SK, Bewtra M, Baumblatt GL, Holubar SD, Greenup AJ, Sechi A, Girgis A, Rubin DT, Siegel CA.

Inflamm Bowel Dis. 2016 Apr;22(4):940-7. doi: 10.1097/MIB.0000000000000740.

PMID:
26950308
7.

Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.

Bewtra M, Fairchild AO, Gilroy E, Leiman DA, Kerner C, Johnson FR, Lewis JD.

Am J Gastroenterol. 2015 Dec;110(12):1675-81. doi: 10.1038/ajg.2015.321. Epub 2015 Oct 20.

PMID:
26482859
8.

Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection.

Henao MP, Bewtra M, Osterman MT, Aberra FN, Scott FI, Lichtenstein GR, Kraschnewski J, Lewis JD.

Inflamm Bowel Dis. 2015 Oct;21(10):2262-71. doi: 10.1097/MIB.0000000000000496.

9.

Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study.

Bewtra M, Newcomb CW, Wu Q, Chen L, Xie F, Roy JA, Aarons CB, Osterman MT, Forde KA, Curtis JR, Lewis JD.

Ann Intern Med. 2015 Aug 18;163(4):262-70. doi: 10.7326/M14-0960.

10.

Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.

Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M.

Gastroenterology. 2015 Sep;149(3):567-76.e3; quiz e13-4. doi: 10.1053/j.gastro.2015.04.013. Epub 2015 Apr 24.

11.

Effectiveness and Safety of Immunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.

Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger CM, Chen L, Xie F, Curtis JR, Lewis JD.

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1293-1301.e5; quiz e70, e72. doi: 10.1016/j.cgh.2015.02.017. Epub 2015 Feb 24.

12.

Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.

Small AJ, Sutherland SE, Hightower JS, Guarner-Argente C, Furth EE, Kochman ML, Forde KA, Bewtra M, Falk GW, Ginsberg GG.

Gastrointest Endosc. 2015 May;81(5):1158-66.e1-4. doi: 10.1016/j.gie.2014.10.029. Epub 2015 Jan 31.

PMID:
25650071
13.

An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo Score and the Simple Clinical Colitis Activity Index.

Bewtra M.

Inflamm Bowel Dis. 2015 Jan;21(1):E1. doi: 10.1097/MIB.0000000000000256. No abstract available.

PMID:
25479459
14.

The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model.

Scott FI, Vajravelu RK, Bewtra M, Mamtani R, Lee D, Goldberg DS, Lewis JD.

Clin Gastroenterol Hepatol. 2015 Feb;13(2):302-309.e11. doi: 10.1016/j.cgh.2014.07.058. Epub 2014 Aug 10.

15.

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, Loftus EV Jr, Peyrin-Biroulet L, Blonski WC, Van Domselaar M, Chaparro M, Sandilya S, Bewtra M, Beigel F, Biancone L, Lichtenstein GR.

Clin Gastroenterol Hepatol. 2015 May;13(5):847-58.e4; quiz e48-50. doi: 10.1016/j.cgh.2014.05.015. Epub 2014 May 28.

PMID:
24879926
16.

Adherence to the 2011 American Gastroenterological Association medical position statement for the diagnosis and management of Barrett's esophagus.

Menezes A, Tierney A, Yang YX, Forde KA, Bewtra M, Metz D, Ginsberg GG, Falk GW.

Dis Esophagus. 2015 Aug-Sep;28(6):538-46. doi: 10.1111/dote.12228. Epub 2014 May 21.

PMID:
24849246
17.

An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.

Bewtra M, Brensinger CM, Tomov VT, Hoang TB, Sokach CE, Siegel CA, Lewis JD.

Inflamm Bowel Dis. 2014 Jun;20(6):1070-8. doi: 10.1097/MIB.0000000000000053.

18.

Patient preferences for surgical versus medical therapy for ulcerative colitis.

Bewtra M, Kilambi V, Fairchild AO, Siegel CA, Lewis JD, Johnson FR.

Inflamm Bowel Dis. 2014 Jan;20(1):103-14. doi: 10.1097/01.MIB.0000437498.14804.50.

19.

Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis.

Alenghat T, Osborne LC, Saenz SA, Kobuley D, Ziegler CG, Mullican SE, Choi I, Grunberg S, Sinha R, Wynosky-Dolfi M, Snyder A, Giacomin PR, Joyce KL, Hoang TB, Bewtra M, Brodsky IE, Sonnenberg GF, Bushman FD, Won KJ, Lazar MA, Artis D.

Nature. 2013 Dec 5;504(7478):153-7. doi: 10.1038/nature12687. Epub 2013 Nov 3.

20.
21.

Comparative effectiveness of infliximab and adalimumab for Crohn's disease.

Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger C, Chen L, Xie F, Curtis JR, Lewis JD.

Clin Gastroenterol Hepatol. 2014 May;12(5):811-817.e3. doi: 10.1016/j.cgh.2013.06.010. Epub 2013 Jun 28.

22.

Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Bewtra M, Kaiser LM, TenHave T, Lewis JD.

Inflamm Bowel Dis. 2013 Mar;19(3):599-613. doi: 10.1097/MIB.0b013e31827f27ae.

23.

Lymphoma in inflammatory bowel disease and treatment decisions.

Bewtra M.

Am J Gastroenterol. 2012 Jul;107(7):964-70. doi: 10.1038/ajg.2011.479. Review.

PMID:
22764018
24.

Linking long-term dietary patterns with gut microbial enterotypes.

Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD.

Science. 2011 Oct 7;334(6052):105-8. doi: 10.1126/science.1208344. Epub 2011 Sep 1.

25.

Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes.

Bahirwani R, Shaked O, Bewtra M, Forde K, Reddy KR.

Transplantation. 2011 Oct 27;92(8):952-7. doi: 10.1097/TP.0b013e31822e6eda.

PMID:
21869735
26.

Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.

Bewtra M, Lewis JD.

Expert Rev Clin Immunol. 2010 Jul;6(4):621-31. doi: 10.1586/eci.10.36. Review.

27.

Safety profile of IBD: lymphoma risks.

Bewtra M, Lewis JD.

Med Clin North Am. 2010 Jan;94(1):93-113. doi: 10.1016/j.mcna.2009.08.015.

PMID:
19944800
28.

Safety profile of IBD: lymphoma risks.

Bewtra M, Lewis JD.

Gastroenterol Clin North Am. 2009 Dec;38(4):669-89. doi: 10.1016/j.gtc.2009.07.004. Review.

PMID:
19913208
29.

Secular trends in hospitalization for IBD: the ecological niche.

Bewtra M, Lewis JD.

Dig Dis Sci. 2009 Sep;54(9):1815-7. doi: 10.1007/s10620-009-0807-3. Epub 2009 Apr 28. No abstract available.

PMID:
19399618
30.

Clinical challenges and images in GI. Image 2: schistosomiasis.

Bewtra M, Burkart AN, Aberra FN.

Gastroenterology. 2009 Feb;136(2):405, 731. doi: 10.1053/j.gastro.2008.05.043. Epub 2008 Dec 26. No abstract available.

PMID:
19111724
31.

Passive smoking and inflammatory bowel disease: a meta-analysis.

Jones DT, Osterman MT, Bewtra M, Lewis JD.

Am J Gastroenterol. 2008 Sep;103(9):2382-93. doi: 10.1111/j.1572-0241.2008.01999.x.

32.

Trends in hospitalization rates for inflammatory bowel disease in the United States.

Bewtra M, Su C, Lewis JD.

Clin Gastroenterol Hepatol. 2007 May;5(5):597-601. Epub 2007 Mar 26.

PMID:
17382602
33.

Predictors of hospital charges for children admitted with asthma.

Gupta RS, Bewtra M, Prosser LA, Finkelstein JA.

Ambul Pediatr. 2006 Jan-Feb;6(1):15-20.

PMID:
16443178
34.

Infliximab use in Crohn's disease.

Bewtra M, Lichtenstein GR.

Expert Opin Biol Ther. 2005 Apr;5(4):589-99. Review.

PMID:
15934836
35.

Gold Foundation essay. The clinical experience that taught me the most.

Bewtra M.

Acad Med. 2002 Sep;77(9):892-3. No abstract available.

PMID:
12228086

Supplemental Content

Loading ...
Support Center